Research

Explore the scientific areas to which the Strickland Laboratory contributes.

Read about glioblastoma surgery and treatments

Research Interest

I am a neurosurgeon-scientist focused on developing novel immunotherapies against glioblastoma. My laboratory leverages single-cell analysis, spatial transcriptomics, and focused ultrasound to unravel the immunosuppressive tumor microenvironment of GBM and translate molecular insights into targeted treatments. Our work also investigates glioblastoma epigenetics to inform our approach to brain tumor immunology.

— Ben Strickland, MD

Strickland Brain Lab research

Active Research Areas

Glioblastoma Immunotherapy & Tumor Microenvironment

Our lab investigates the immunosuppressive tumor microenvironment (TME) in glioblastoma, with a focus on tumor-associated macrophages (TAMs). We study how GBM manipulates myeloid cell populations to evade immune detection and clearance, with the goal of identifying actionable therapeutic targets. This work integrates single-cell analysis, spatial transcriptomics, and functional assays to map resistance mechanisms and develop novel immunotherapy strategies.

Focused Ultrasound for Brain Tumor Treatment

Focused ultrasound (FUS) is a noninvasive energy delivery technology capable of precisely modulating the tumor microenvironment through acoustic waves. Our lab engineers FUS approaches to transiently open the blood-brain barrier, enhance drug delivery, and activate anti-tumor immune responses in glioblastoma. We investigate how FUS parameters can be optimized for maximal therapeutic effect while preserving healthy tissue.

CAR-T Cell Therapy for Glioblastoma

Chimeric antigen receptor (CAR) T-cell therapy represents a promising frontier in GBM treatment. Our research evaluates current clinical insights, addresses challenges such as antigen heterogeneity and the immunosuppressive microenvironment, and explores engineering approaches to enhance CAR-T persistence and function within the central nervous system.

Glioblastoma Epigenetics

We investigate epigenetic mechanisms underlying glioblastoma progression, therapeutic resistance, and immune evasion, informing our broader understanding of brain tumor immunology.

Endoscopic & Minimally Invasive Brain Tumor Surgery

Leveraging advanced endoscopic and minimally invasive neurosurgical techniques, we refine surgical approaches for brain tumors including glioblastoma and pituitary adenomas. Our work focuses on improving resection rates, reducing complications, and characterizing long-term outcomes through multi-institutional collaboration.

Positions & Appointments

2023–Present

Assistant Professor, Department of Neurosurgery

Medical University of South Carolina, Charleston, SC

2022–2023

Fellow, Skull Base and Cerebrovascular

Department of Neurosurgery, Emory University, Atlanta, GA

2021–2022

Fellow, Skull Base and Neuro-Oncology

Department of Neurosurgery, University of Southern California, Los Angeles, CA

2015–2021

Resident Physician

Department of Neurosurgery, University of Southern California, Los Angeles, CA

2013–2015

Research Associate

Department of Neurosurgery, MD Anderson Cancer Center, Houston, TX

Education

Residency · June 2022

Neurological Surgery

University of Southern California, Los Angeles, CA

Fellowship · June 2021

Skull Base & Neuro-Oncology

University of Southern California, Los Angeles, CA

MD · May 2015

Medicine

Baylor College of Medicine, Houston, TX

BA · May 2011

Economics

Clemson University, Clemson, SC

BA · May 2011

Biology

Clemson University, Clemson, SC